 | • レポートコード：QY2108PAL8918 • 出版社/出版日：QYResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、164ページ • 納品方法：Eメール（納期：1日） • 産業分類：医薬品 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の当調査資料ではグローバルにおけるポイントオブケア・迅速診断の市場規模（2016年-2027年）と動向についてまとめました。中国市場については主要プレイヤーの市場シェア、ポイントオブケア・迅速診断の種類別市場規模（集中治療室、新型コロナウイルス感染症検査、感染症検査、心臓マーカー検査、凝固検査、その他）、用途別市場規模（病院、クリニック、独立研究所、その他）も掲載しています。他に、北米・アメリカ市場、ヨーロッパ市場、アジア太平洋・日本市場、中南米市場、中東・アフリカ市場の市場規模、グローバル市場機会・課題・リスク要因、バリューチェーン・販売チャネル、主要プレイヤーの情報なども掲載しています。 ・調査の概要 ・調査のサマリー ・世界のポイントオブケア・迅速診断市場動向 ・グローバル主要プレイヤーの競争状況・市場シェア ・世界におけるポイントオブケア・迅速診断の種類別市場規模（2016年-2027年）：集中治療室、新型コロナウイルス感染症検査、感染症検査、心臓マーカー検査、凝固検査、その他 ・世界におけるポイントオブケア・迅速診断の用途別市場規模（2016年-2027年）：病院、クリニック、独立研究所、その他 ・ポイントオブケア・迅速診断の中国市場分析 - ポイントオブケア・迅速診断の中国市場規模（2016年-2027年） - 中国におけるポイントオブケア・迅速診断の主要プレイヤー別市場シェア - 中国におけるポイントオブケア・迅速診断の種類別市場規模：集中治療室、新型コロナウイルス感染症検査、感染症検査、心臓マーカー検査、凝固検査、その他 - 中国におけるポイントオブケア・迅速診断の用途別市場規模：病院、クリニック、独立研究所、その他 ・ポイントオブケア・迅速診断の北米市場（2016年-2027年） ・ポイントオブケア・迅速診断のヨーロッパ市場（2016年-2027年） ・ポイントオブケア・迅速診断のアジア太平洋市場（2016年-2027年） ・ポイントオブケア・迅速診断の中南米市場（2016年-2027年） ・ポイントオブケア・迅速診断の中東・アフリカ市場（2016年-2027年） ・主要プレイヤーの情報：Roche、Abbott、Danaher、Siemens Healthcare、Bio-Rad Laboratories、BioMerieux、Nova Biomedical、Thermo Fisher Scientific、Quidel、A. Menarini Diagnostics、Becton Dickinson、Biosurfit、Astrego Diagnostics、Werfen、Abionic、Palex Medical/Bülhmann、Horiba Medical、RAL、Vircell、Monlab、Binding Site ・市場機会・課題・リスク要因分析 ・バリューチェーン・販売チャネル分析 ・... |
Point-of-care testing (POCT or bedside testing) is defined as medical diagnostic testing at or near the point of care—that is, at the time and place of patient care.
In our report, blood glucose test strips and blood glucose meter, which mainly used at home, are not included.
In Spain & Portugal Market, Oint-of-Care or Rapid Diagnostics key players include, Roche, Abbott, Danaher, Siemens Healthcare, Bio-Rad Laboratories, etc. Top 5 manufacturers hold a share over 74%.
In terms of product, Intensive Care is the largest segment, with a share over 19%. And in terms of application, the largest application is Hospital, followed by Clinic, Independent Laboratories and Others.
Market Analysis and Insights: Global and China Point-Of-Care Or Rapid Diagnostics Market
This report focuses on global and China Point-Of-Care Or Rapid Diagnostics market.
In 2020, the global Point-Of-Care Or Rapid Diagnostics market size was US$ XX million and it is expected to reach US$ XX million by the end of 2027, with a CAGR of XX% during 2021-2027. In China the Point-Of-Care Or Rapid Diagnostics market size is expected to grow from US$ XX million in 2020 to US$ XX million by 2027, at a CAGR of XX% during the forecast period.
Global Point-Of-Care Or Rapid Diagnostics Scope and Market Size
Point-Of-Care Or Rapid Diagnostics market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Point-Of-Care Or Rapid Diagnostics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027.
For China market, this report focuses on the Point-Of-Care Or Rapid Diagnostics market size by players, by Type, and by Application, for the period 2016-2027. The key players include the global and local players which play important roles in China.
Segment by Type
Intensive Care
Covid-19 Testing
Infectious Diseases Testing
Cardiac Markers Testing
Coagulation Testing
Others
Segment by Application
Hospital
Clinic
Independent Laboratories
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
Roche
Abbott
Danaher
Siemens Healthcare
Bio-Rad Laboratories
BioMerieux
Nova Biomedical
Thermo Fisher Scientific
Quidel
A. Menarini Diagnostics
Becton Dickinson
Biosurfit
Astrego Diagnostics
Werfen
Abionic
Palex Medical/Bülhmann
Horiba Medical
RAL
Vircell
Monlab
Binding Site
1 Study Coverage
1.1 Point-Of-Care Or Rapid Diagnostics Product Introduction
1.2 Market by Type
1.2.1 Global Point-Of-Care Or Rapid Diagnostics Market Size Growth Rate by Type
1.2.2 Intensive Care
1.2.3 Covid-19 Testing
1.2.4 Infectious Diseases Testing
1.2.5 Cardiac Markers Testing
1.2.6 Coagulation Testing
1.2.7 Others
1.3 Market by Application
1.3.1 Global Point-Of-Care Or Rapid Diagnostics Market Size Growth Rate by Application
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Independent Laboratories
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Point-Of-Care Or Rapid Diagnostics Market Size, Estimates and Forecasts
2.1.1 Global Point-Of-Care Or Rapid Diagnostics Revenue 2016-2027
2.1.2 Global Point-Of-Care Or Rapid Diagnostics Sales 2016-2027
2.2 Global Point-Of-Care Or Rapid Diagnostics, Market Size by Region: 2016 VS 2021 VS 2027
2.3 Point-Of-Care Or Rapid Diagnostics Historical Market Size by Region (2016-2021)
2.3.1 Global Point-Of-Care Or Rapid Diagnostics Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Point-Of-Care Or Rapid Diagnostics Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Point-Of-Care Or Rapid Diagnostics Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Point-Of-Care Or Rapid Diagnostics Sales Forecast by Region (2022-2027)
2.4.2 Global Point-Of-Care Or Rapid Diagnostics Revenue Forecast by Region (2022-2027)
3 Global Point-Of-Care Or Rapid Diagnostics Competitor Landscape by Players
3.1 Global Top Point-Of-Care Or Rapid Diagnostics Manufacturers by Sales
3.1.1 Global Point-Of-Care Or Rapid Diagnostics Sales by Manufacturer (2016-2021)
3.1.2 Global Point-Of-Care Or Rapid Diagnostics Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Point-Of-Care Or Rapid Diagnostics Manufacturers by Revenue
3.2.1 Key Point-Of-Care Or Rapid Diagnostics Manufacturers Covered: Ranking by Revenue
3.2.2 Global Point-Of-Care Or Rapid Diagnostics Revenue by Manufacturers (2016-2021)
3.2.3 Global Point-Of-Care Or Rapid Diagnostics Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Point-Of-Care Or Rapid Diagnostics Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Point-Of-Care Or Rapid Diagnostics Revenue in 2020
3.2.6 Global Point-Of-Care Or Rapid Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Point-Of-Care Or Rapid Diagnostics Price by Manufacturers
3.4 Global Point-Of-Care Or Rapid Diagnostics Manufacturing Base Distribution, Product Types
3.4.1 Point-Of-Care Or Rapid Diagnostics Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Point-Of-Care Or Rapid Diagnostics Product Type
3.4.3 Date of International Manufacturers Enter into Point-Of-Care Or Rapid Diagnostics Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2016-2027)
4.1 Global Point-Of-Care Or Rapid Diagnostics Market Size by Type (2016-2021)
4.1.1 Global Point-Of-Care Or Rapid Diagnostics Sales by Type (2016-2021)
4.1.2 Global Point-Of-Care Or Rapid Diagnostics Revenue by Type (2016-2021)
4.1.3 Point-Of-Care Or Rapid Diagnostics Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Point-Of-Care Or Rapid Diagnostics Market Size Forecast by Type (2022-2027)
4.2.1 Global Point-Of-Care Or Rapid Diagnostics Sales Forecast by Type (2022-2027)
4.2.2 Global Point-Of-Care Or Rapid Diagnostics Revenue Forecast by Type (2022-2027)
4.2.3 Point-Of-Care Or Rapid Diagnostics Average Selling Price (ASP) Forecast by Type (2022-2027)
5 Breakdown Data by Application (2016-2027)
5.1 Global Point-Of-Care Or Rapid Diagnostics Market Size by Application (2016-2021)
5.1.1 Global Point-Of-Care Or Rapid Diagnostics Sales by Application (2016-2021)
5.1.2 Global Point-Of-Care Or Rapid Diagnostics Revenue by Application (2016-2021)
5.1.3 Point-Of-Care Or Rapid Diagnostics Price by Application (2016-2021)
5.2 Point-Of-Care Or Rapid Diagnostics Market Size Forecast by Application (2022-2027)
5.2.1 Global Point-Of-Care Or Rapid Diagnostics Sales Forecast by Application (2022-2027)
5.2.2 Global Point-Of-Care Or Rapid Diagnostics Revenue Forecast by Application (2022-2027)
5.2.3 Global Point-Of-Care Or Rapid Diagnostics Price Forecast by Application (2022-2027)
6 China by Players, Type and Application
6.1 China Point-Of-Care Or Rapid Diagnostics Market Size YoY Growth 2016-2027
6.1.1 China Point-Of-Care Or Rapid Diagnostics Sales YoY Growth 2016-2027
6.1.2 China Point-Of-Care Or Rapid Diagnostics Revenue YoY Growth 2016-2027
6.1.3 China Point-Of-Care Or Rapid Diagnostics Market Share in Global Market 2016-2027
6.2 China Point-Of-Care Or Rapid Diagnostics Market Size by Players (International and Local Players)
6.2.1 China Top Point-Of-Care Or Rapid Diagnostics Players by Sales (2016-2021)
6.2.2 China Top Point-Of-Care Or Rapid Diagnostics Players by Revenue (2016-2021)
6.3 China Point-Of-Care Or Rapid Diagnostics Historic Market Review by Type (2016-2021)
6.3.1 China Point-Of-Care Or Rapid Diagnostics Sales Market Share by Type (2016-2021)
6.3.2 China Point-Of-Care Or Rapid Diagnostics Revenue Market Share by Type (2016-2021)
6.3.3 China Point-Of-Care Or Rapid Diagnostics Price by Type (2016-2021)
6.4 China Point-Of-Care Or Rapid Diagnostics Market Estimates and Forecasts by Type (2022-2027)
6.4.1 China Point-Of-Care Or Rapid Diagnostics Sales Forecast by Type (2022-2027)
6.4.2 China Point-Of-Care Or Rapid Diagnostics Revenue Forecast by Type (2022-2027)
6.4.3 China Point-Of-Care Or Rapid Diagnostics Price Forecast by Type (2022-2027)
6.5 China Point-Of-Care Or Rapid Diagnostics Historic Market Review by Application (2016-2021)
6.5.1 China Point-Of-Care Or Rapid Diagnostics Sales Market Share by Application (2016-2021)
6.5.2 China Point-Of-Care Or Rapid Diagnostics Revenue Market Share by Application (2016-2021)
6.5.3 China Point-Of-Care Or Rapid Diagnostics Price by Application (2016-2021)
6.6 China Point-Of-Care Or Rapid Diagnostics Market Estimates and Forecasts by Application (2022-2027)
6.6.1 China Point-Of-Care Or Rapid Diagnostics Sales Forecast by Application (2022-2027)
6.6.2 China Point-Of-Care Or Rapid Diagnostics Revenue Forecast by Application (2022-2027)
6.6.3 China Point-Of-Care Or Rapid Diagnostics Price Forecast by Application (2022-2027)
7 North America
7.1 North America Point-Of-Care Or Rapid Diagnostics Market Size YoY Growth 2016-2027
7.2 North America Point-Of-Care Or Rapid Diagnostics Market Facts & Figures by Country
7.2.1 North America Point-Of-Care Or Rapid Diagnostics Sales by Country (2016-2021)
7.2.2 North America Point-Of-Care Or Rapid Diagnostics Revenue by Country (2016-2021)
7.2.3 United States
7.2.4 Canada
8 Asia Pacific
8.1 Asia Pacific Point-Of-Care Or Rapid Diagnostics Market Size YoY Growth 2016-2027
8.2 Asia Pacific Point-Of-Care Or Rapid Diagnostics Market Facts & Figures by Region
8.2.1 Asia Pacific Point-Of-Care Or Rapid Diagnostics Sales by Region (2016-2021)
8.2.2 Asia Pacific Point-Of-Care Or Rapid Diagnostics Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
9 Europe
9.1 Europe Point-Of-Care Or Rapid Diagnostics Market Size YoY Growth 2016-2027
9.2 Europe Point-Of-Care Or Rapid Diagnostics Market Facts & Figures by Country
9.2.1 Europe Point-Of-Care Or Rapid Diagnostics Sales by Country (2016-2021)
9.2.2 Europe Point-Of-Care Or Rapid Diagnostics Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy
10 Latin America
10.1 Latin America Point-Of-Care Or Rapid Diagnostics Market Size YoY Growth 2016-2027
10.2 Latin America Point-Of-Care Or Rapid Diagnostics Market Facts & Figures by Country
10.2.1 Latin America Point-Of-Care Or Rapid Diagnostics Sales by Country (2016-2021)
10.2.2 Latin America Point-Of-Care Or Rapid Diagnostics Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Point-Of-Care Or Rapid Diagnostics Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Point-Of-Care Or Rapid Diagnostics Market Facts & Figures by Country
11.2.1 Middle East and Africa Point-Of-Care Or Rapid Diagnostics Sales by Country (2016-2021)
11.2.2 Middle East and Africa Point-Of-Care Or Rapid Diagnostics Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 UAE
12 Company Profiles
12.1 Roche
12.1.1 Roche Corporation Information
12.1.2 Roche Description and Business Overview
12.1.3 Roche Point-Of-Care Or Rapid Diagnostics Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Roche Point-Of-Care Or Rapid Diagnostics Products Offered
12.1.5 Roche Recent Development
12.2 Abbott
12.2.1 Abbott Corporation Information
12.2.2 Abbott Description and Business Overview
12.2.3 Abbott Point-Of-Care Or Rapid Diagnostics Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Abbott Point-Of-Care Or Rapid Diagnostics Products Offered
12.2.5 Abbott Recent Development
12.3 Danaher
12.3.1 Danaher Corporation Information
12.3.2 Danaher Description and Business Overview
12.3.3 Danaher Point-Of-Care Or Rapid Diagnostics Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Danaher Point-Of-Care Or Rapid Diagnostics Products Offered
12.3.5 Danaher Recent Development
12.4 Siemens Healthcare
12.4.1 Siemens Healthcare Corporation Information
12.4.2 Siemens Healthcare Description and Business Overview
12.4.3 Siemens Healthcare Point-Of-Care Or Rapid Diagnostics Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Siemens Healthcare Point-Of-Care Or Rapid Diagnostics Products Offered
12.4.5 Siemens Healthcare Recent Development
12.5 Bio-Rad Laboratories
12.5.1 Bio-Rad Laboratories Corporation Information
12.5.2 Bio-Rad Laboratories Description and Business Overview
12.5.3 Bio-Rad Laboratories Point-Of-Care Or Rapid Diagnostics Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Bio-Rad Laboratories Point-Of-Care Or Rapid Diagnostics Products Offered
12.5.5 Bio-Rad Laboratories Recent Development
12.6 BioMerieux
12.6.1 BioMerieux Corporation Information
12.6.2 BioMerieux Description and Business Overview
12.6.3 BioMerieux Point-Of-Care Or Rapid Diagnostics Sales, Revenue and Gross Margin (2016-2021)
12.6.4 BioMerieux Point-Of-Care Or Rapid Diagnostics Products Offered
12.6.5 BioMerieux Recent Development
12.7 Nova Biomedical
12.7.1 Nova Biomedical Corporation Information
12.7.2 Nova Biomedical Description and Business Overview
12.7.3 Nova Biomedical Point-Of-Care Or Rapid Diagnostics Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Nova Biomedical Point-Of-Care Or Rapid Diagnostics Products Offered
12.7.5 Nova Biomedical Recent Development
12.8 Thermo Fisher Scientific
12.8.1 Thermo Fisher Scientific Corporation Information
12.8.2 Thermo Fisher Scientific Description and Business Overview
12.8.3 Thermo Fisher Scientific Point-Of-Care Or Rapid Diagnostics Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Thermo Fisher Scientific Point-Of-Care Or Rapid Diagnostics Products Offered
12.8.5 Thermo Fisher Scientific Recent Development
12.9 Quidel
12.9.1 Quidel Corporation Information
12.9.2 Quidel Description and Business Overview
12.9.3 Quidel Point-Of-Care Or Rapid Diagnostics Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Quidel Point-Of-Care Or Rapid Diagnostics Products Offered
12.9.5 Quidel Recent Development
12.10 A. Menarini Diagnostics
12.10.1 A. Menarini Diagnostics Corporation Information
12.10.2 A. Menarini Diagnostics Description and Business Overview
12.10.3 A. Menarini Diagnostics Point-Of-Care Or Rapid Diagnostics Sales, Revenue and Gross Margin (2016-2021)
12.10.4 A. Menarini Diagnostics Point-Of-Care Or Rapid Diagnostics Products Offered
12.10.5 A. Menarini Diagnostics Recent Development
12.11 Roche
12.11.1 Roche Corporation Information
12.11.2 Roche Description and Business Overview
12.11.3 Roche Point-Of-Care Or Rapid Diagnostics Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Roche Point-Of-Care Or Rapid Diagnostics Products Offered
12.11.5 Roche Recent Development
12.12 Biosurfit
12.12.1 Biosurfit Corporation Information
12.12.2 Biosurfit Description and Business Overview
12.12.3 Biosurfit Point-Of-Care Or Rapid Diagnostics Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Biosurfit Products Offered
12.12.5 Biosurfit Recent Development
12.13 Astrego Diagnostics
12.13.1 Astrego Diagnostics Corporation Information
12.13.2 Astrego Diagnostics Description and Business Overview
12.13.3 Astrego Diagnostics Point-Of-Care Or Rapid Diagnostics Sales, Revenue and Gross Margin (2016-2021)
12.13.4 Astrego Diagnostics Products Offered
12.13.5 Astrego Diagnostics Recent Development
12.14 Werfen
12.14.1 Werfen Corporation Information
12.14.2 Werfen Description and Business Overview
12.14.3 Werfen Point-Of-Care Or Rapid Diagnostics Sales, Revenue and Gross Margin (2016-2021)
12.14.4 Werfen Products Offered
12.14.5 Werfen Recent Development
12.15 Abionic
12.15.1 Abionic Corporation Information
12.15.2 Abionic Description and Business Overview
12.15.3 Abionic Point-Of-Care Or Rapid Diagnostics Sales, Revenue and Gross Margin (2016-2021)
12.15.4 Abionic Products Offered
12.15.5 Abionic Recent Development
12.16 Palex Medical/Bülhmann
12.16.1 Palex Medical/Bülhmann Corporation Information
12.16.2 Palex Medical/Bülhmann Description and Business Overview
12.16.3 Palex Medical/Bülhmann Point-Of-Care Or Rapid Diagnostics Sales, Revenue and Gross Margin (2016-2021)
12.16.4 Palex Medical/Bülhmann Products Offered
12.16.5 Palex Medical/Bülhmann Recent Development
12.17 Horiba Medical
12.17.1 Horiba Medical Corporation Information
12.17.2 Horiba Medical Description and Business Overview
12.17.3 Horiba Medical Point-Of-Care Or Rapid Diagnostics Sales, Revenue and Gross Margin (2016-2021)
12.17.4 Horiba Medical Products Offered
12.17.5 Horiba Medical Recent Development
12.18 RAL
12.18.1 RAL Corporation Information
12.18.2 RAL Description and Business Overview
12.18.3 RAL Point-Of-Care Or Rapid Diagnostics Sales, Revenue and Gross Margin (2016-2021)
12.18.4 RAL Products Offered
12.18.5 RAL Recent Development
12.19 Vircell
12.19.1 Vircell Corporation Information
12.19.2 Vircell Description and Business Overview
12.19.3 Vircell Point-Of-Care Or Rapid Diagnostics Sales, Revenue and Gross Margin (2016-2021)
12.19.4 Vircell Products Offered
12.19.5 Vircell Recent Development
12.20 Monlab
12.20.1 Monlab Corporation Information
12.20.2 Monlab Description and Business Overview
12.20.3 Monlab Point-Of-Care Or Rapid Diagnostics Sales, Revenue and Gross Margin (2016-2021)
12.20.4 Monlab Products Offered
12.20.5 Monlab Recent Development
12.21 Binding Site
12.21.1 Binding Site Corporation Information
12.21.2 Binding Site Description and Business Overview
12.21.3 Binding Site Point-Of-Care Or Rapid Diagnostics Sales, Revenue and Gross Margin (2016-2021)
12.21.4 Binding Site Products Offered
12.21.5 Binding Site Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Point-Of-Care Or Rapid Diagnostics Industry Trends
13.2 Point-Of-Care Or Rapid Diagnostics Market Drivers
13.3 Point-Of-Care Or Rapid Diagnostics Market Challenges
13.4 Point-Of-Care Or Rapid Diagnostics Market Restraints
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Point-Of-Care Or Rapid Diagnostics Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Global Point-Of-Care Or Rapid Diagnostics Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Intensive Care
Table 3. Major Manufacturers of Covid-19 Testing
Table 4. Major Manufacturers of Infectious Diseases Testing
Table 5. Major Manufacturers of Cardiac Markers Testing
Table 6. Major Manufacturers of Coagulation Testing
Table 7. Major Manufacturers of Others
Table 8. Global Point-Of-Care Or Rapid Diagnostics Market Size Growth Rate by Application (2021-2027) & (K Doses)
Table 9. Global Point-Of-Care Or Rapid Diagnostics Market Size by Region (K Doses) & (US$ Million), 2016 VS 2021 VS 2027
Table 10. Global Point-Of-Care Or Rapid Diagnostics Sales by Regions (2016-2021) & (K Doses)
Table 11. Global Point-Of-Care Or Rapid Diagnostics Sales Market Share by Regions (2016-2021)
Table 12. Global Point-Of-Care Or Rapid Diagnostics Revenue by Regions (2016-2021) & (US$ Million)
Table 13. Global Point-Of-Care Or Rapid Diagnostics Sales Forecast by Region (2022-2027) & (K Doses)
Table 14. Global Point-Of-Care Or Rapid Diagnostics Sales Market Share Forecast by Region (2022-2027)
Table 15. Global Point-Of-Care Or Rapid Diagnostics Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 16. Global Point-Of-Care Or Rapid Diagnostics Revenue Market Share Forecast by Region (2022-2027)
Table 17. Global Point-Of-Care Or Rapid Diagnostics Sales by Manufacturers (2016-2021) (K Doses)
Table 18. Global Point-Of-Care Or Rapid Diagnostics Sales Share by Manufacturers (2016-2021)
Table 19. Ranking of Global Top Point-Of-Care Or Rapid Diagnostics Manufacturers by Revenue (US$ Million) in 2020
Table 20. Point-Of-Care Or Rapid Diagnostics Revenue by Manufacturers (2016-2021) (US$ Million)
Table 21. Point-Of-Care Or Rapid Diagnostics Revenue Share by Manufacturers (2016-2021)
Table 22. Global Point-Of-Care Or Rapid Diagnostics Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
Table 23. Global Point-Of-Care Or Rapid Diagnostics by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Point-Of-Care Or Rapid Diagnostics as of 2020)
Table 24. Key Manufacturers Point-Of-Care Or Rapid Diagnostics Price (2016-2021) (US$/Dose)
Table 25. Point-Of-Care Or Rapid Diagnostics Manufacturers Manufacturing Base Distribution and Headquarters
Table 26. Manufacturers Point-Of-Care Or Rapid Diagnostics Product Type
Table 27. Date of International Manufacturers Enter into Point-Of-Care Or Rapid Diagnostics Market
Table 28. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 29. Global Point-Of-Care Or Rapid Diagnostics Sales by Type (2016-2021) (K Doses)
Table 30. Global Point-Of-Care Or Rapid Diagnostics Sales Share by Type (2016-2021)
Table 31. Global Point-Of-Care Or Rapid Diagnostics Revenue by Type (2016-2021) (US$ Million)
Table 32. Global Point-Of-Care Or Rapid Diagnostics Revenue Share by Type (2016-2021)
Table 33. Point-Of-Care Or Rapid Diagnostics Average Selling Price (ASP) by Type (2016-2021) & (US$/Dose)
Table 34. Global Point-Of-Care Or Rapid Diagnostics Sales Forecast by Type (2022-2027) & (K Doses)
Table 35. Global Point-Of-Care Or Rapid Diagnostics Sales Market Share Forecast by Type (2022-2027)
Table 36. Global Point-Of-Care Or Rapid Diagnostics Revenue Forecast V (2022-2027) & (US$ Million)
Table 37. Global Point-Of-Care Or Rapid Diagnostics Revenue Market Share Forecast by Type (2022-2027)
Table 38. Global Point-Of-Care Or Rapid Diagnostics Average Selling Price (ASP) Forecast by Type (2022-2027) & (US$/Dose)
Table 39. Global Point-Of-Care Or Rapid Diagnostics Sales by Application (2016-2021) (K Doses)
Table 40. Global Point-Of-Care Or Rapid Diagnostics Sales Share by Application (2016-2021)
Table 41. Global Point-Of-Care Or Rapid Diagnostics Revenue by Application (2016-2021) (US$ Million)
Table 42. Global Point-Of-Care Or Rapid Diagnostics Revenue Share by Application (2016-2021)
Table 43. Point-Of-Care Or Rapid Diagnostics Average Selling Price (ASP) by Application (2016-2021) & (US$/Dose)
Table 44. Global Point-Of-Care Or Rapid Diagnostics Sales Forecast by Application (2022-2027) & (K Doses)
Table 45. Global Point-Of-Care Or Rapid Diagnostics Sales Market Share Forecast by Application (2022-2027)
Table 46. Global Point-Of-Care Or Rapid Diagnostics Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 47. Global Point-Of-Care Or Rapid Diagnostics Revenue Market Share Forecast by Application (2022-2027)
Table 48. Global Point-Of-Care Or Rapid Diagnostics Average Selling Price (ASP) Forecast by Application (2022-2027) & (US$/Dose)
Table 49. China Point-Of-Care Or Rapid Diagnostics Sales (K Doses) of Key Companies (2016-2021)
Table 50. China Point-Of-Care Or Rapid Diagnostics Sales Share by Company (2016-2021)
Table 51. China Point-Of-Care Or Rapid Diagnostics Revenue (US$ Million) by Company (2016-2021)
Table 52. China Point-Of-Care Or Rapid Diagnostics Revenue Share by Company (2016-2021)
Table 53. China Point-Of-Care Or Rapid Diagnostics Sales (K Doses) by Type (2016-2021)
Table 54. China Point-Of-Care Or Rapid Diagnostics Sales Share by Type (2016-2021)
Table 55. China Point-Of-Care Or Rapid Diagnostics Revenue (US$ Million) Market Share by Type (2016-2021)
Table 56. China Point-Of-Care Or Rapid Diagnostics Price (US$/Dose) by Type (2016-2021)
Table 57. China Point-Of-Care Or Rapid Diagnostics Sales (K Doses) by Type (2022-2027)
Table 58. China Point-Of-Care Or Rapid Diagnostics Sales Share by Type (2022-2027)
Table 59. China Point-Of-Care Or Rapid Diagnostics Revenue (US$ Million) Market Share by Type (2022-2027)
Table 60. China Point-Of-Care Or Rapid Diagnostics Revenue Share by Type (2022-2027)
Table 61. China Point-Of-Care Or Rapid Diagnostics Price (US$/Dose) by Type (2022-2027)
Table 62. China Point-Of-Care Or Rapid Diagnostics Sales (K Doses) by Application (2016-2021)
Table 63. China Point-Of-Care Or Rapid Diagnostics Sales Share by Application (2016-2021)
Table 64. China Point-Of-Care Or Rapid Diagnostics Revenue (US$ Million) Market Share by Application (2016-2021)
Table 65. China Point-Of-Care Or Rapid Diagnostics Price (US$/Dose) by Application (2016-2021)
Table 66. China Point-Of-Care Or Rapid Diagnostics Sales (K Doses) by Application (2022-2027)
Table 67. China Point-Of-Care Or Rapid Diagnostics Sales Share by Application (2022-2027)
Table 68. China Point-Of-Care Or Rapid Diagnostics Revenue (US$ Million) Market Share by Application (2022-2027)
Table 69. China Point-Of-Care Or Rapid Diagnostics Revenue Share by Application (2022-2027)
Table 70. China Point-Of-Care Or Rapid Diagnostics Price (US$/Dose) by Application (2022-2027)
Table 71. North America Point-Of-Care Or Rapid Diagnostics Sales by Country (2016-2021) & (K Doses)
Table 72. North America Point-Of-Care Or Rapid Diagnostics Sales Market Share by Country (2016-2021)
Table 73. North America Point-Of-Care Or Rapid Diagnostics Revenue by Country (2016-2021) & (US$ Million)
Table 74. North America Point-Of-Care Or Rapid Diagnostics Revenue Market Share by Country (2016-2021)
Table 75. Asia Pacific Point-Of-Care Or Rapid Diagnostics Sales by Region (2016-2021) & (K Doses)
Table 76. Asia Pacific Point-Of-Care Or Rapid Diagnostics Sales Market Share by Region (2016-2021)
Table 77. Asia Pacific Point-Of-Care Or Rapid Diagnostics Revenue by Region (2016-2021) & (US$ Million)
Table 78. Asia Pacific Point-Of-Care Or Rapid Diagnostics Revenue Market Share by Region (2016-2021)
Table 79. Europe Point-Of-Care Or Rapid Diagnostics Sales by Country (2016-2021) & (K Doses)
Table 80. Europe Point-Of-Care Or Rapid Diagnostics Sales Market Share by Country (2016-2021)
Table 81. Europe Point-Of-Care Or Rapid Diagnostics Revenue by Country (2016-2021) & (US$ Million)
Table 82. Europe Point-Of-Care Or Rapid Diagnostics Revenue Market Share by Country (2016-2021)
Table 83. Latin America Point-Of-Care Or Rapid Diagnostics Sales by Country (2016-2021) & (K Doses)
Table 84. Latin America Point-Of-Care Or Rapid Diagnostics Sales Market Share by Country (2016-2021)
Table 85. Latin Americaa Point-Of-Care Or Rapid Diagnostics Revenue by Country (2016-2021) & (US$ Million)
Table 86. Latin America Point-Of-Care Or Rapid Diagnostics Revenue Market Share by Country (2016-2021)
Table 87. Middle East and Africa Point-Of-Care Or Rapid Diagnostics Sales by Country (2016-2021) & (K Doses)
Table 88. Middle East and Africa Point-Of-Care Or Rapid Diagnostics Sales Market Share by Country (2016-2021)
Table 89. Middle East and Africa Point-Of-Care Or Rapid Diagnostics Revenue by Country (2016-2021) & (US$ Million)
Table 90. Middle East and Africa Point-Of-Care Or Rapid Diagnostics Revenue Market Share by Country (2016-2021)
Table 91. Roche Corporation Information
Table 92. Roche Description and Business Overview
Table 93. Roche Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2016-2021)
Table 94. Roche Point-Of-Care Or Rapid Diagnostics Product
Table 95. Roche Recent Development
Table 96. Abbott Corporation Information
Table 97. Abbott Description and Business Overview
Table 98. Abbott Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2016-2021)
Table 99. Abbott Product
Table 100. Abbott Recent Development
Table 101. Danaher Corporation Information
Table 102. Danaher Description and Business Overview
Table 103. Danaher Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2016-2021)
Table 104. Danaher Product
Table 105. Danaher Recent Development
Table 106. Siemens Healthcare Corporation Information
Table 107. Siemens Healthcare Description and Business Overview
Table 108. Siemens Healthcare Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2016-2021)
Table 109. Siemens Healthcare Product
Table 110. Siemens Healthcare Recent Development
Table 111. Bio-Rad Laboratories Corporation Information
Table 112. Bio-Rad Laboratories Description and Business Overview
Table 113. Bio-Rad Laboratories Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2016-2021)
Table 114. Bio-Rad Laboratories Product
Table 115. Bio-Rad Laboratories Recent Development
Table 116. BioMerieux Corporation Information
Table 117. BioMerieux Description and Business Overview
Table 118. BioMerieux Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2016-2021)
Table 119. BioMerieux Product
Table 120. BioMerieux Recent Development
Table 121. Nova Biomedical Corporation Information
Table 122. Nova Biomedical Description and Business Overview
Table 123. Nova Biomedical Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2016-2021)
Table 124. Nova Biomedical Product
Table 125. Nova Biomedical Recent Development
Table 126. Thermo Fisher Scientific Corporation Information
Table 127. Thermo Fisher Scientific Description and Business Overview
Table 128. Thermo Fisher Scientific Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2016-2021)
Table 129. Thermo Fisher Scientific Product
Table 130. Thermo Fisher Scientific Recent Development
Table 131. Quidel Corporation Information
Table 132. Quidel Description and Business Overview
Table 133. Quidel Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2016-2021)
Table 134. Quidel Product
Table 135. Quidel Recent Development
Table 136. A. Menarini Diagnostics Corporation Information
Table 137. A. Menarini Diagnostics Description and Business Overview
Table 138. A. Menarini Diagnostics Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2016-2021)
Table 139. A. Menarini Diagnostics Product
Table 140. A. Menarini Diagnostics Recent Development
Table 141. Becton Dickinson Corporation Information
Table 142. Becton Dickinson Description and Business Overview
Table 143. Becton Dickinson Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2016-2021)
Table 144. Becton Dickinson Product
Table 145. Becton Dickinson Recent Development
Table 146. Biosurfit Corporation Information
Table 147. Biosurfit Description and Business Overview
Table 148. Biosurfit Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2016-2021)
Table 149. Biosurfit Product
Table 150. Biosurfit Recent Development
Table 151. Astrego Diagnostics Corporation Information
Table 152. Astrego Diagnostics Description and Business Overview
Table 153. Astrego Diagnostics Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2016-2021)
Table 154. Astrego Diagnostics Product
Table 155. Astrego Diagnostics Recent Development
Table 156. Werfen Corporation Information
Table 157. Werfen Description and Business Overview
Table 158. Werfen Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2016-2021)
Table 159. Werfen Product
Table 160. Werfen Recent Development
Table 161. Abionic Corporation Information
Table 162. Abionic Description and Business Overview
Table 163. Abionic Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2016-2021)
Table 164. Abionic Product
Table 165. Abionic Recent Development
Table 166. Palex Medical/Bülhmann Corporation Information
Table 167. Palex Medical/Bülhmann Description and Business Overview
Table 168. Palex Medical/Bülhmann Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2016-2021)
Table 169. Palex Medical/Bülhmann Product
Table 170. Palex Medical/Bülhmann Recent Development
Table 171. Horiba Medical Corporation Information
Table 172. Horiba Medical Description and Business Overview
Table 173. Horiba Medical Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2016-2021)
Table 174. Horiba Medical Product
Table 175. Horiba Medical Recent Development
Table 176. RAL Corporation Information
Table 177. RAL Description and Business Overview
Table 178. RAL Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2016-2021)
Table 179. RAL Product
Table 180. RAL Recent Development
Table 181. Vircell Corporation Information
Table 182. Vircell Description and Business Overview
Table 183. Vircell Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2016-2021)
Table 184. Vircell Product
Table 185. Vircell Recent Development
Table 186. Monlab Corporation Information
Table 187. Monlab Description and Business Overview
Table 188. Monlab Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2016-2021)
Table 189. Monlab Product
Table 190. Monlab Recent Development
Table 191. Binding Site Corporation Information
Table 192. Binding Site Description and Business Overview
Table 193. Binding Site Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2016-2021)
Table 194. Binding Site Product
Table 195. Binding Site Recent Development
Table 196. Point-Of-Care Or Rapid Diagnostics Market Trends
Table 197. Point-Of-Care Or Rapid Diagnostics Market Drivers
Table 198. Point-Of-Care Or Rapid Diagnostics Market Challenges
Table 199. Point-Of-Care Or Rapid Diagnostics Market Restraints
Table 200. Point-Of-Care Or Rapid Diagnostics Customers List
Table 201. Point-Of-Care Or Rapid Diagnostics Distributors List
Table 202. Research Programs/Design for This Report
Table 203. Key Data Information from Secondary Sources
Table 204. Key Data Information from Primary Sources
List of Figures
Figure 1. Point-Of-Care Or Rapid Diagnostics Product Picture
Figure 2. Global Point-Of-Care Or Rapid Diagnostics Sales Market Share by Type in 2020 & 2027
Figure 3. Intensive Care Product Picture
Figure 4. Covid-19 Testing Product Picture
Figure 5. Infectious Diseases Testing Product Picture
Figure 6. Cardiac Markers Testing Product Picture
Figure 7. Coagulation Testing Product Picture
Figure 8. Others Product Picture
Figure 9. Global Point-Of-Care Or Rapid Diagnostics Sales Market Share by Application in 2020 & 2027
Figure 10. Hospital
Figure 11. Clinic
Figure 12. Independent Laboratories
Figure 13. Others
Figure 14. Point-Of-Care Or Rapid Diagnostics Report Years Considered
Figure 15. Global Point-Of-Care Or Rapid Diagnostics Market Size, (US$ Million), 2016 VS 2021 VS 2027
Figure 16. Global Point-Of-Care Or Rapid Diagnostics Market Size 2016-2027 (US$ Million)
Figure 17. Global Point-Of-Care Or Rapid Diagnostics Sales 2016-2027 (K Doses)
Figure 18. Global Point-Of-Care Or Rapid Diagnostics Market Size Market Share by Region: 2021 Versus 2027
Figure 19. Global Point-Of-Care Or Rapid Diagnostics Sales Market Share by Region (2016-2021)
Figure 20. Global Point-Of-Care Or Rapid Diagnostics Sales Market Share by Region in 2020
Figure 21. Global Point-Of-Care Or Rapid Diagnostics Revenue Market Share by Region (2016-2021)
Figure 22. Global Point-Of-Care Or Rapid Diagnostics Revenue Market Share by Region in 2020
Figure 23. Global Point-Of-Care Or Rapid Diagnostics Sales Share by Manufacturer in 2020
Figure 24. The Top 10 and 5 Players Market Share by Point-Of-Care Or Rapid Diagnostics Revenue in 2020
Figure 25. Point-Of-Care Or Rapid Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 26. Global Point-Of-Care Or Rapid Diagnostics Sales Market Share by Type (2016-2021)
Figure 27. Global Point-Of-Care Or Rapid Diagnostics Sales Market Share by Type in 2020
Figure 28. Global Point-Of-Care Or Rapid Diagnostics Revenue Market Share by Type (2016-2021)
Figure 29. Global Point-Of-Care Or Rapid Diagnostics Revenue Market Share by Type in 2020
Figure 30. Global Point-Of-Care Or Rapid Diagnostics Sales Market Share by Application (2016-2021)
Figure 31. Global Point-Of-Care Or Rapid Diagnostics Sales Market Share by Application in 2020
Figure 32. Global Point-Of-Care Or Rapid Diagnostics Revenue Market Share by Application (2016-2021)
Figure 33. Global Point-Of-Care Or Rapid Diagnostics Revenue Market Share by Application in 2020
Figure 34. China Point-Of-Care Or Rapid Diagnostics Sales Growth Rate 2016-2027 (K Doses)
Figure 35. China Point-Of-Care Or Rapid Diagnostics Revenue Growth Rate 2016-2027 (US$ Million)
Figure 36. China Point-Of-Care Or Rapid Diagnostics Market Share in Global Market 2016-2027
Figure 37. China 5 and 10 Largest Point-Of-Care Or Rapid Diagnostics Players Market Share by Revenue in Point-Of-Care Or Rapid Diagnostics in 2020
Figure 38. China Point-Of-Care Or Rapid Diagnostics Revenue Share by Type (2016-2021)
Figure 39. China Point-Of-Care Or Rapid Diagnostics Revenue Growth Rate by Type in 2016 & 2020
Figure 40. China Point-Of-Care Or Rapid Diagnostics Revenue Share by Application (2016-2021)
Figure 41. China Point-Of-Care Or Rapid Diagnostics Revenue Growth Rate by Application in 2016 & 2020
Figure 42. North America Point-Of-Care Or Rapid Diagnostics Sales Growth Rate 2016-2021 (K Doses)
Figure 43. North America Point-Of-Care Or Rapid Diagnostics Revenue Growth Rate 2016-2021 (US$ Million)
Figure 44. North America Point-Of-Care Or Rapid Diagnostics Sales Market Share by Country in 2020
Figure 45. North America Point-Of-Care Or Rapid Diagnostics Revenue Market Share by Country in 2020
Figure 46. United States Point-Of-Care Or Rapid Diagnostics Sales Growth Rate (2016-2021) (K Doses)
Figure 47. United States Point-Of-Care Or Rapid Diagnostics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 48. Canada Point-Of-Care Or Rapid Diagnostics Sales Growth Rate (2016-2021) (K Doses)
Figure 49. Canada Point-Of-Care Or Rapid Diagnostics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 50. Europe Point-Of-Care Or Rapid Diagnostics Sales Growth Rate 2016-2021 (K Doses)
Figure 51. Europe Point-Of-Care Or Rapid Diagnostics Revenue Growth Rate 2016-2021 (US$ Million)
Figure 52. Europe Point-Of-Care Or Rapid Diagnostics Sales Market Share by Country in 2020
Figure 53. Europe Point-Of-Care Or Rapid Diagnostics Revenue Market Share by Country in 2020
Figure 54. Germany Point-Of-Care Or Rapid Diagnostics Sales Growth Rate (2016-2021) (K Doses)
Figure 55. Germany Point-Of-Care Or Rapid Diagnostics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 56. France Point-Of-Care Or Rapid Diagnostics Sales Growth Rate (2016-2021) (K Doses)
Figure 57. France Point-Of-Care Or Rapid Diagnostics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 58. U.K. Point-Of-Care Or Rapid Diagnostics Sales Growth Rate (2016-2021) (K Doses)
Figure 59. U.K. Point-Of-Care Or Rapid Diagnostics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 60. Italy Point-Of-Care Or Rapid Diagnostics Sales Growth Rate (2016-2021) (K Doses)
Figure 61. Italy Point-Of-Care Or Rapid Diagnostics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 62. Russia Point-Of-Care Or Rapid Diagnostics Sales Growth Rate (2016-2021) (K Doses)
Figure 63. Russia Point-Of-Care Or Rapid Diagnostics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 64. Asia Pacific Point-Of-Care Or Rapid Diagnostics Sales Growth Rate 2016-2021 (K Doses)
Figure 65. Asia Pacific Point-Of-Care Or Rapid Diagnostics Revenue Growth Rate 2016-2021 (US$ Million)
Figure 66. Asia Pacific Point-Of-Care Or Rapid Diagnostics Sales Market Share by Region in 2020
Figure 67. Asia Pacific Point-Of-Care Or Rapid Diagnostics Revenue Market Share by Region in 2020
Figure 68. China Point-Of-Care Or Rapid Diagnostics Sales Growth Rate (2016-2021) (K Doses)
Figure 69. China Point-Of-Care Or Rapid Diagnostics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 70. Japan Point-Of-Care Or Rapid Diagnostics Sales Growth Rate (2016-2021) (K Doses)
Figure 71. Japan Point-Of-Care Or Rapid Diagnostics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 72. South Korea Point-Of-Care Or Rapid Diagnostics Sales Growth Rate (2016-2021) (K Doses)
Figure 73. South Korea Point-Of-Care Or Rapid Diagnostics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 74. India Point-Of-Care Or Rapid Diagnostics Sales Growth Rate (2016-2021) (K Doses)
Figure 75. India Point-Of-Care Or Rapid Diagnostics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 76. Australia Point-Of-Care Or Rapid Diagnostics Sales Growth Rate (2016-2021) (K Doses)
Figure 77. Australia Point-Of-Care Or Rapid Diagnostics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 78. China Taiwan Point-Of-Care Or Rapid Diagnostics Sales Growth Rate (2016-2021) (K Doses)
Figure 79. China Taiwan Point-Of-Care Or Rapid Diagnostics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 80. Indonesia Point-Of-Care Or Rapid Diagnostics Sales Growth Rate (2016-2021) (K Doses)
Figure 81. Indonesia Point-Of-Care Or Rapid Diagnostics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 82. Thailand Point-Of-Care Or Rapid Diagnostics Sales Growth Rate (2016-2021) (K Doses)
Figure 83. Thailand Point-Of-Care Or Rapid Diagnostics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 84. Malaysia Point-Of-Care Or Rapid Diagnostics Sales Growth Rate (2016-2021) (K Doses)
Figure 85. Malaysia Point-Of-Care Or Rapid Diagnostics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 86. Latin America Point-Of-Care Or Rapid Diagnostics Sales Growth Rate 2016-2021 (K Doses)
Figure 87. Latin America Point-Of-Care Or Rapid Diagnostics Revenue Growth Rate 2016-2021 (US$ Million)
Figure 88. Latin America Point-Of-Care Or Rapid Diagnostics Sales Market Share by Country in 2020
Figure 89. Latin America Point-Of-Care Or Rapid Diagnostics Revenue Market Share by Country in 2020
Figure 90. Mexico Point-Of-Care Or Rapid Diagnostics Sales Growth Rate (2016-2021) (K Doses)
Figure 91. Mexico Point-Of-Care Or Rapid Diagnostics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 92. Brazil Point-Of-Care Or Rapid Diagnostics Sales Growth Rate (2016-2021) (K Doses)
Figure 93. Brazil Point-Of-Care Or Rapid Diagnostics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 94. Argentina Point-Of-Care Or Rapid Diagnostics Sales Growth Rate (2016-2021) (K Doses)
Figure 95. Argentina Point-Of-Care Or Rapid Diagnostics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 96. Middle East and Africa Point-Of-Care Or Rapid Diagnostics Sales Growth Rate 2016-2021 (K Doses)
Figure 97. Middle East and Africa Point-Of-Care Or Rapid Diagnostics Revenue Growth Rate 2016-2021 (US$ Million)
Figure 98. Middle East and Africa Point-Of-Care Or Rapid Diagnostics Sales Market Share by Country in 2020
Figure 99. Middle East and Africa Point-Of-Care Or Rapid Diagnostics Revenue Market Share by Country in 2020
Figure 100. Turkey Point-Of-Care Or Rapid Diagnostics Sales Growth Rate (2016-2021) (K Doses)
Figure 101. Turkey Point-Of-Care Or Rapid Diagnostics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 102. Saudi Arabia Point-Of-Care Or Rapid Diagnostics Sales Growth Rate (2016-2021) (K Doses)
Figure 103. Saudi Arabia Point-Of-Care Or Rapid Diagnostics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 104. UAE Point-Of-Care Or Rapid Diagnostics Sales Growth Rate (2016-2021) (K Doses)
Figure 105. UAE Point-Of-Care Or Rapid Diagnostics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 106. Point-Of-Care Or Rapid Diagnostics Value Chain
Figure 107. Channels of Distribution
Figure 108. Distributors Profiles
Figure 109. Bottom-up and Top-down Approaches for This Report
Figure 110. Data Triangulation
Figure 111. Key Executives Interviewed
ポイントオブケア凝固検査の世界市場 2020年 Market Overview The global Point-of-Care Coagulation Testing market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Point-of-Ca…- ポイントオブケア検査（POCT）の世界市場 2020年 Market Overview The Point-of-Care Testing (POCT) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimi…
- ポイントオブケア診断（POCD）の世界市場 2020年 Market Overview The global Point of Care Diagnostics (POCD) market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Point of Car…
- ポイントオブケアブドウ糖検査の世界市場 2020年 Market Overview The global Point-of-Care Glucose Testing market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Point-of-Care G…
- ポイントオブケア検査（POCT）デバイスの世界市場 2020年 Market Overview The global Point-of-Care Testing (POCT) Devices market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Point-of…